CREDIT SUISSE AG/ - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 34 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2022$867,112
-33.8%
800,000
-38.7%
0.00%0.0%
Q3 2022$1,310,000
+332.3%
1,305,000
+337.9%
0.00%
Q1 2022$303,000
-85.5%
298,000
-85.2%
0.00%
-100.0%
Q4 2021$2,095,0002,010,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2021
NameSharesValueWeighting ↓
Wellesley Asset Management 52,096$55,6723.77%
MACKAY SHIELDS LLC 77,043,000$83,172,6052.12%
Sonora Investment Management Group, LLC 7,960,000$8,654,4090.79%
Lombard Odier Asset Management (Europe) Ltd 12,390,000$17,994,3790.73%
BRAIDWELL LP 19,200,000$20,727,5680.70%
ADVENT CAPITAL MANAGEMENT /DE/ 32,064,000$34,615,0440.60%
LOOMIS SAYLES & CO L P 2,089,754$216,2690.43%
Liberty Mutual Group Asset Management Inc. 825,000$8870.24%
PALISADE CAPITAL MANAGEMENT, LP 3,143,000$3,386,5830.09%
THRIVENT FINANCIAL FOR LUTHERANS 15,950,000$17,1390.04%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders